PROK Stock Summary and Trading Ideas (Prokidney Corp. - Class A | NASDAQ:PROK)

ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

What symbol and exchange does Prokidney Corp. - Class A shares trade?

Prokidney Corp. - Class A trades on the NASDAQ stock market under the symbol PROK.

What is Prokidney Corp. - Class A stock price doing today?

As of June 18, 2026, PROK stock price climbed to $1.83 with 554,677 million shares trading.

What is Prokidney Corp. - Class A's Beta?

PROK has a beta of 1.26, meaning it tends to be more sensitive to market movements. PROK has a correlation of 0.01 to the broad based SPY ETF.

How much is Prokidney Corp. - Class A worth?

PROK has a market cap of $375.52 million. This is considered a Small Cap stock.

How much money does Prokidney Corp. - Class A make?

Last quarter Prokidney Corp. - Class A reported $226,000 in Revenue and -$.14 earnings per share. This beat revenue expectation by $131,800 and met earnings estimates .

What is the highest and lowest price Prokidney Corp. - Class A traded in the last 3 year period?

In the last 3 years, PROK traded as high as $13.51 and as low as $.46.

What are the top ETFs holding Prokidney Corp. - Class A?

The top ETF exchange traded funds that PROK belongs to (by Net Assets): VXF, SCHA, BBC, SCHB.

Is Prokidney Corp. - Class A (PROK) a good investment?

PROK has outperformed the market in the last year with a price return of +113.3% while the SPY ETF gained +26.2%. However, in the short term, PROK had mixed performance relative to the market. It has underperformed in the last 3 months, returning -14.1% vs +11.6% return in SPY. But in the last 2 weeks, PROK shares have fared better than the market returning +5.8% compared to SPY -1.0%.

What are the support and resistance levels for Prokidney Corp. - Class A (PROK)?

PROK support price is $1.67 and resistance is $1.83 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PROK shares will trade within this expected range on the day.